CATALYST BIOSCIENCES INC filings

SEC filings by CATALYST BIOSCIENCES INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G2011-02-08BlackRock Inc.TARGACEPT INC1,879,8606.6%EDGAR
SC 13G/A2010-02-16FMR LLCTARGACEPT INC4,099,65414.8%EDGAR
SC 13G/A2010-02-16BIOTECHNOLOGY VALUE FUND L PTARGACEPT INC418,3681.5%EDGAR
SC 13G/A2010-02-12WELLINGTON MANAGEMENT CO LLPTARGACEPT INC3,408,21512.3%EDGAR
SC 13G/A2010-02-12NOMURA INTERNATIONAL PLCTARGACEPT INC519,7161.9%EDGAR
SC 13G/A2010-02-12GLAXOSMITHKLINE PLCTARGACEPT INC1,013,5534.0%EDGAR
SC 13G/A2010-02-12Visium Asset Management, LPTARGACEPT INC1,352,0594.9%EDGAR
SC 13G2010-02-12SECTORAL ASSET MANAGEMENT INCTARGACEPT INC1,464,4125.3%EDGAR
SC 13G/A2010-02-03EuclidSR Partners, L.P.TARGACEPT INC556,6312.0%EDGAR
SC 13G/A2009-10-20BIOTECHNOLOGY VALUE FUND L PTARGACEPT INC465,4251.8%EDGAR
SC 13G2009-09-10FMR LLCTARGACEPT INC2,802,91111.2%EDGAR
SC 13G2009-08-03Visium Asset Management, LPTARGACEPT INC1,420,3235.7%EDGAR
SC 13G/A2009-07-14BIOTECHNOLOGY VALUE FUND L PTARGACEPT INC653,5092.6%EDGAR
SC 13G/A2009-02-17GLAXOSMITHKLINE PLCTARGACEPT INC1,424,1765.7%EDGAR
SC 13G/A2009-02-17WELLINGTON MANAGEMENT CO LLPTARGACEPT INC3,304,88213.2%EDGAR
SC 13G/A2009-02-12EuclidSR Partners, L.P.TARGACEPT INC1,152,6314.6%EDGAR
SC 13G/A2009-01-27BIOTECHNOLOGY VALUE FUND L PTARGACEPT INC472,3011.9%EDGAR
SC 13G/A2008-02-14BIOTECHNOLOGY VALUE FUND L PTARGACEPT INC230,5301.1%EDGAR
SC 13G/A2008-02-14WELLINGTON MANAGEMENT CO LLPTARGACEPT INC1,632,1598.0%EDGAR
SC 13G/A2008-02-12OXFORD BIOSCIENCE PARTNERS IV LPTARGACEPT INC--EDGAR